Edwards Lifesciences’ artificial aortic valve technology opens the way for innovative heart surgery, which promises to reduce costs, as well as patient recovery time.
Sr. Reconciliation Administrator
Brown Advisory (2011 - 2012)
Baltimore MD | Senior Operations Associate
JPMorgan Chase (2010 - 2011)
Jersey City, NJ | Performance Analysis
Fortigent (2007 - 2009)
Rockville, MD | Senior Analyst
Barclays Capital (2004 - 2006)
New York, NY | Static Data Analyst
University of Maryland, College Park - BS, Finance (1999)
Sands Capital is an active, long-term investor in leading innovative businesses globally. Our approach combines rigorous fundamental analysis with creative thinking to identify high-quality growth businesses that are creating the future. Through strategies designed to concentrate investment in these businesses, we serve the long-term growth objectives of institutions and fund sponsors in more than 40 countries.
An independent, staff-owned firm based in the Greater Washington, DC area, Sands Capital managed more than USD $68 billion in client assets as of December 31, 2020.
© 2021 Sands Capital Management. All Rights Reserved.
For institutional and professional investors only.